Boehringer Ingelheim and Lilly provide update on Jardiance® phase III exercise ability studies in chronic heart failure - P&T Community

Boehringer Ingelheim and Lilly provide update on Jardiance® phase III exercise ability studies in chronic heart failure  P&T Community